Notre Dame Intermédica Participações S.A. (BOVESPA:GNDI3) entered into a purchase and sale intent agreement to acquire Lifeday Planos de Saúde Ltda for an enterprise value for BRL 70 million on October 1, 2020. Under the terms of transaction, purchase price will be paid in cash on closing date, adjusted by the net cash and an escrow account for future contingencies. Lifeday has a portfolio of approximately 57 thousand healthcare beneficiaries, located mainly in the estates of Santa Catarina and Rio Grande do Sul, with 95.8% in the corporate/SME category. Lifeday presented in the last twelve months ended June 2020, a consolidated net revenue of BRL 95 million. The closing of the transaction is subject to the approval by the Brazilian Agency of Supplemental Health (Agência Nacional de Saúde Suplementar - ANS) and the Brazilian Antitrust Council (Conselho Administrativo de Defesa Econômica – CADE).